143.72 USD
↘ 1.09 (0.75%)AT CLOSE (11:59 AM EDT)
Gilead Sciences Inc
GILDNASDAQ • USD
143.94
↗ 0.22 (0.15%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
143.94
↗ 0.22 (0.15%)
Market: CLOSED
Gilead Sciences Inc (GILD) trades at $143.72 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place GILD at a fair price relative to peers.
Technical & fundamental data as of Sep 11, 2026.
Open?$145.24
High?$145.99
Low?$143.50
Prev. Close?$144.81
Volume?4.2M
Avg. Volume?6.0M
VWAP?$144.11
Rel. Volume?0.70x
Bid / Ask
Bid?$143.43 × 200
Ask?$144.97 × 400
Spread?$1.54
Midpoint?$144.20
Valuation & Ratios
Market Cap?178.2B
Shares Out?1.2B
Float?1.2B
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?15.07
EPS?-$2.61
Dividend?2.28%
Ex-Dividend?2026-09-15
News
Profile
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Themes
Employees
17.0K
Market Cap
179.6B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1992-01-22
Address
333 LAKESIDE DR
FOSTER CITY, CA 94404
Phone: (650) 574-3000
FOSTER CITY, CA 94404
Phone: (650) 574-3000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?82
Momentum?33
Short Sent.?57
Piotroski F-Score?3/9Weak
Altman Z-Score?3.43Safe
Confidence?66%Moderate
Short InterestModerate
Short % of Float?1.86%Low
Short Interest?23.0M
Days to Cover?4.2
Free Float1.2B
Avg Daily Volume5.4M
Settlement Date2026-08-31
Financial Health
Current Ratio?1.27Adequate
Quick Ratio?1.09Adequate
Cash Ratio?0.29Low
Debt/Equity?2.22High
ValuationFAIRLY VALUEDvs 9 peers + S&P 500
Score53/100
P/E?N/A▾
P/B?15.07HIGH▾
Peers22
S&P12
P/S?5.85FAIR▾
Peers60
S&P23
P/FCF?13.8CHEAP▾
Peers100
S&P78
EV/EBITDA?62.4HIGH▾
Peers13
S&P3
EV/Sales?6.61HIGH▾
Peers50
S&P23
Returns & Efficiency
ROE?-27.4%WEAK▾
Peers14
S&P6
ROA?-6.6%WEAK▾
Peers13
S&P3
Cash Flow & Enterprise
FCF?$12.9B
Enterprise Value?$201.3B
Fundamentals ratios updated end of day